Cargando…
Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
Patient: Female, 44 Final Diagnosis: Focal nodular hyperplasia Symptoms: Liver masses Medication: — Clinical Procedure: CT • MRI • Pathology Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Focal nodular hyperplasia (FNH) of the liver is a rare benign nodular lesion that...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683308/ https://www.ncbi.nlm.nih.gov/pubmed/31358723 http://dx.doi.org/10.12659/AJCR.916398 |
_version_ | 1783442062682619904 |
---|---|
author | Fukahori, Susumu Kawano, Tetsuya Obase, Yasushi Umeyama, Yasuhiro Sugasaki, Nanae Kinoshita, Akitoshi Fukushima, Chizu Yamakawa, Masaki Omagari, Katsuhisa Mukae, Hiroshi |
author_facet | Fukahori, Susumu Kawano, Tetsuya Obase, Yasushi Umeyama, Yasuhiro Sugasaki, Nanae Kinoshita, Akitoshi Fukushima, Chizu Yamakawa, Masaki Omagari, Katsuhisa Mukae, Hiroshi |
author_sort | Fukahori, Susumu |
collection | PubMed |
description | Patient: Female, 44 Final Diagnosis: Focal nodular hyperplasia Symptoms: Liver masses Medication: — Clinical Procedure: CT • MRI • Pathology Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Focal nodular hyperplasia (FNH) of the liver is a rare benign nodular lesion that arises in women of reproductive age. Although a role of female hormones has been suggested, their influence on the course of FNH has remained controversial. CASE REPORT: A 44-year-old woman with a 12-year history of oral contraceptive use was referred to our hospital for examination of an asymptomatic liver mass (3 cm in diameter) identified by computed tomography. We diagnosed FNH using imaging methods and fine-needle biopsy. Oral contraceptives were discontinued because the mass increased over a period of 21 months. Four months later, the mass had decreased in size, indicating that FNH can spontaneously regress when oral contraceptives are discontinued. CONCLUSIONS: Discontinuation of oral contraceptives use can reduce the size of FNH, as in this case. |
format | Online Article Text |
id | pubmed-6683308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66833082019-08-26 Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use Fukahori, Susumu Kawano, Tetsuya Obase, Yasushi Umeyama, Yasuhiro Sugasaki, Nanae Kinoshita, Akitoshi Fukushima, Chizu Yamakawa, Masaki Omagari, Katsuhisa Mukae, Hiroshi Am J Case Rep Articles Patient: Female, 44 Final Diagnosis: Focal nodular hyperplasia Symptoms: Liver masses Medication: — Clinical Procedure: CT • MRI • Pathology Specialty: General and Internal Medicine OBJECTIVE: Rare disease BACKGROUND: Focal nodular hyperplasia (FNH) of the liver is a rare benign nodular lesion that arises in women of reproductive age. Although a role of female hormones has been suggested, their influence on the course of FNH has remained controversial. CASE REPORT: A 44-year-old woman with a 12-year history of oral contraceptive use was referred to our hospital for examination of an asymptomatic liver mass (3 cm in diameter) identified by computed tomography. We diagnosed FNH using imaging methods and fine-needle biopsy. Oral contraceptives were discontinued because the mass increased over a period of 21 months. Four months later, the mass had decreased in size, indicating that FNH can spontaneously regress when oral contraceptives are discontinued. CONCLUSIONS: Discontinuation of oral contraceptives use can reduce the size of FNH, as in this case. International Scientific Literature, Inc. 2019-07-30 /pmc/articles/PMC6683308/ /pubmed/31358723 http://dx.doi.org/10.12659/AJCR.916398 Text en © Am J Case Rep, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Articles Fukahori, Susumu Kawano, Tetsuya Obase, Yasushi Umeyama, Yasuhiro Sugasaki, Nanae Kinoshita, Akitoshi Fukushima, Chizu Yamakawa, Masaki Omagari, Katsuhisa Mukae, Hiroshi Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use |
title | Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use |
title_full | Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use |
title_fullStr | Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use |
title_full_unstemmed | Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use |
title_short | Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use |
title_sort | fluctuation of hepatic focal nodular hyperplasia size with oral contraceptives use |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683308/ https://www.ncbi.nlm.nih.gov/pubmed/31358723 http://dx.doi.org/10.12659/AJCR.916398 |
work_keys_str_mv | AT fukahorisusumu fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT kawanotetsuya fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT obaseyasushi fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT umeyamayasuhiro fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT sugasakinanae fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT kinoshitaakitoshi fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT fukushimachizu fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT yamakawamasaki fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT omagarikatsuhisa fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse AT mukaehiroshi fluctuationofhepaticfocalnodularhyperplasiasizewithoralcontraceptivesuse |